Answers are grounded in this paper and cite their sources.
In vitro comparative assay demonstrates potent alpha-glucosidase inhibition by medicinal plant extracts, suggesting promising natural alternatives for postprandial hyperglycemia management.
One of the most important strategies in the management of type 2 diabetes is controlling postprandial hyperglycemia, and α-glucosidase inhibitors are commonly used to achieve this. However, the side effects that may arise from the long-term use of synthetic inhibitors have increased interest in naturally derived alternatives. In this study, the α-glucosidase inhibitory activities of ethanol extracts from Thymus sipyleus Boiss., Salvia officinalis L., and Lavandula stoechas L. were evaluated in comparison with acarbose, a reference inhibitor. The results showed that all plant extracts examined exhibited strong inhibitory activity against α-glucosidase. The highest inhibitory activity was found in S. officinalis (IC50: 2.44±0.086 µg/mL); This was followed by T. sipyleus (2.71±0.40 µg/mL) and acarbose (2.85 ± 0.23 µg/mL). L. stoechas also exhibited significant but lower inhibitory activity (5.68 ± 0.05 µg/mL). The higher α-glucosidase inhibitory activity of S. officinalis and T. sipyleus extracts compared with acarbose suggests that these species may represent promising natural sources of α-glucosidase inhibitors. While the α-glucosidase inhibitory activity of S. officinalis has been previously reported, data regarding T. sipyleus and L. stoechas remain limited. This study provides novel comparative data on the α-glucosidase inhibitory activities of these three species and highlights their potential as promising natural sources of α-glucosidase inhibitors for further investigation.
No takes yet. Share an insight, caveat, or question.
Sevgi Altın (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: